StimLabs® and Geistlich to launch new product in Q2 2026 following expanded partnership started in 2024.
Roswell-based StimLabs revealed today an extended collaboration with Geistlich, a prominent player in regenerative medicine. The partnership, originating in 2024, initially included an exclusive national distribution deal to offer their products.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments